The cancer-induced increase of integrin expression in EC as well as the reciprocal expression of the integrin ligands, VCAM-1 and ICAM-1, on the surface of the cancer cells is the opposite to what is described for the interactions between EC and ALL cells as well as EC and normal lymphocytes. Here, VCAM1 is linked to cancer.